PRFX Painreform Ltd
Company Analysis
Latest News
π’ Painreform is trading 11% up today as GridFeed AI explores hyperscale data-center power optimization
Painreform is trading 11% up at $1.00 while PRF Technologies explores the hyperscale data-center power-optimization market through its GridFeed AI energy...
π’ Painreform is trading 9% up today
Painreform is trading at $0.98 (+8.90%), with no reliable catalyst currently explaining the gain. - No confirmed September 16, 2026 company-specific...
π’ Painreform is trading 6.79% up today with no confirmed catalyst
Painreform is trading at $0.92, up +6.79%, with the move appearing driven by thin-liquidity trading or short-term technical activity rather than a confirmed...
π’ Painreform is trading 5.7% up today β catalyst unconfirmed
Painreform is trading 5.7% up at $0.89, but no company-specific catalyst has been confirmed. - No fresh company-specific announcement, filing, earnings...
π’ Painreform is trading 6.93% up in pre-market with no fresh company-specific catalyst identified
Painreform is trading at $0.92, up 6.93%, with no fresh company-specific catalyst identified. - It closed at $0.86 on September 11, 2026. - GridFeedβs planned...
π’ Painreform is trading 7% up in after-hours trading with no clear company-specific catalyst
Painreform is trading 6.96% up now at $0.92 after closing at $0.86 on September 11, 2026, with no fresh company-specific catalyst identified for the...
π΄ Painreform is trading 5.1% down today with no clear company-specific catalyst
Painreform is trading 5.1% down at $0.88 after no clear company-specific catalyst emerged for September 11, 2026. - Recent coverage referenced a planned...
π’ Painreform is trading 6.88% up today in pre-market with catalyst unclear
Painreform is trading 6.88% up at $1.01 in pre-market, with the catalyst unclear. - No verified company-specific announcement dated September 9, 2026, was...
π΄ Painreform is trading 5.54% down today in pre-market with immediate catalyst unclear
Painreform is trading 5.54% down at $0.92 after declining from its September 2, 2026 close of $0.97; no clear immediate catalyst was identified. - No...
π’ Painreform is trading 10.83% up in pre-market
Painreform is trading 10.83% up now at $1.08 after rising from the September 2 close of $0.97. - No clear company-specific announcement, earnings release, or...
π’ Painreform is trading 6.18% up in pre-market with no clear company-specific catalyst
Painreform is trading 6.18% up in pre-market at $1.01, with no clear company-specific catalyst identified for September 2, 2026. - The latest identifiable...
π’ Painreform is trading 7.09% up in pre-market β no confirmed company-specific catalyst identified
Painreform is trading 7.09% up at $1.03 after closing at $0.96 on August 28, 2026, with no confirmed company-specific catalyst identified. - No confirmed...
π’ Painreform is trading 8.1% up in pre-market with no confirmed company-specific catalyst
Painreform is trading at $1.07, up +8.10%, with no confirmed company-specific announcement dated August 28, 2026 identified. - The latest listed company news...
π’ Painreform is trading 6.93% up in pre-market amid broader market strength
Painreform is trading at $1.08 (+6.93%) in pre-market, with the gain appearing more consistent with broader market strength than a newly reported...
π’ Painreform is trading 5.31% up in after-hours trading with no company-specific announcement explaining move
Painreform is trading 5.31% up at $1.05 in after-hours trading, with no reliable company-specific announcement dated August 21 directly explaining the move. -...
π’ Painreform is trading 5% up today β no clear catalyst identified
Painreform is trading 5% up at $1.05, based on the provided live quote, with no reliable company-specific announcement dated August 21, 2026 identified to...
π’ Painreform rises 6.2% β Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
π΄ Painreform is trading 5.3% down today; no clear catalyst identified
Painreform is trading at $0.97 (-5.34%), with no clear company-specific catalyst identified. - Painreform declined 14.17% to $1.03 on August 14, 2026. - No...
π΄ Painreform is trading 5.8% down in pre-market
Painreform is trading 5.8% down at $0.97, with no clear company-specific catalyst identified. - Painreform fell 14.17% to $1.03 on August 14, 2026. - No...
π΄ Painreform is trading 11% down today with no clear catalyst identified
Painreform is trading at $1.07 (-10.83%) with no clear company-specific catalyst identified. - No company-specific announcement, filing, earnings release, or...